Prevalence of Metabolic Syndrome Among People Attending the Combined Clinic in Al-Qardah Al-Shati Area and Its Relationship to Gender and Age
Article Sidebar
-
Blood Pressure, Cardiovascular Disease, Diabetes, Dyslipidemia, Metabolic Syndrome
Abstract
Metabolic syndrome is one of the most prevalent metabolic disorders that increase the risk of developing type 2 diabetes and cardiovascular disease. This study was conducted to find out the prevalence of this syndrome among people attending the combined clinic in Al-Qardah Al-Shati area, according to the criteria of NCEP ATP III, and demonstrate its relationship to gender and age. The subjects were divided into two groups, according to the incidence of metabolic syndrome (control and patient). Arthrometric measurements and venous blood samples were collected from them to measure the concentration of fat and sugar in serum. The data were statistically analyzed using the SPSS 20 program. The results showed a significant difference between the two groups in all variables under study (P-value less than 0.05) except for systolic pressure, total cholesterol, and low-density cholesterol. It was also found that the prevalence of the syndrome among the study population was 58.23%, as it was higher in women than in men, which respectively amounted to 48 (52.17%) and 44 (47.83%). In addition, it was higher among the ages of 40 - 59 years. The study concluded that the prevalence of metabolic syndrome is high, especially in women and in the fourth and sixth decades of age.
Full text article
References
[1]-Saklayen, M.G., The global epidemic of the metabolic syndrome.Current hypertension reports, 2018. 20(2): p. 1-8.
[2]-Pammer, L.M., et al., Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort.Journal of Internal Medicine, 2021. 290(6): p. 1219-1232.
[3]-Swarup, S., etal., Metabolic syndrome.StatPearls
[internet], 2021.
[4]-Wang, H.H., et al., Novel insights into the pathogenesis and management of the metabolic syndrome.PediatricGastroenterology, Hepatology & Nutrition, 2020. 23(3): p. 189.
[5]-Anagnostis, P., et al., The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis.The Journal of Clinical Endocrinology & Metabolism, 2009. 94(8): p. 2692-2701.
[6]-Garcez ,A., et al., Basal cortisol levels and metabolic syndrome: A systematic review and meta-analysis ofobservational studies.Psychoneuroendocrinology, 2018. 95: p. 50-62.
[7]-Reisinger, C., Nkeh-Chungag, B. N., Fredriksen, P. M., & Goswami, N. (2021). The prevalence of pediatric metabolic syndrome—A critical look on the discrepancies between definitions and its clinical importance.International Journal of Obesity,45(1), 12-24.
[8]-García‐Jiménez, S., Bernal Fernandez, G., Martinez Salazar, M. F., Monroy Noyola, A., Toledano Jaimes, C., Meneses Acosta, A., ... & Sánchez‐Alemán, M. A. (2015). Serum leptin is associated with metabolic syndrome in obese Mexican subjects.Journal of clinical laboratory analysis,29(1), 5-9.
[9]-Sinclair, A. J., Dunning, T., Mañas, L. R., & Munshi, M. (Eds.). (2017).Diabetes in old age.John Wiley & Sons.
[10]-Laakso, M. and P.T. Kovanen, Metabolic syndrome: To be or not to be?Annals of medicine, 2006. 38(1): p. 32-33.
[11]-Hirode, G. and R.J. Wong, Trends in the prevalence of metabolic syndrome in the United States, 2011-2016.Jama, 2020. 323(24): p. 2526-2528.
[12]-Delavari, A., Forouzanfar, M. H., Alikhani, S., Sharifian, A., & Kelishadi, R. (2009). First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran.Diabetes care,32(6), 1092-1097
[13]-Rochlani, Y., Pothineni, N. V., Kovelamudi, S., & Mehta, J. L. (2017). Metabolic syndrome: pathophysiology, management, and modulation by natural compounds.Therapeutic advances in cardiovascular disease,11(8), 215-225.
[14]-O'Neill, S. and L. O'Driscoll, Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.Obesity reviews, 2015. 16(1): p. 1-12.
[15]-Hajat ,C. and Z. Shather, Prevalence of metabolic syndrome and prediction of diabetes using IDF versus ATPIII criteria in a Middle East population.Diabetes research and clinical practice, 2012. 98(3): p. 481-486.
[16]-Al-Qahtani, D.A. and M.L. Imtiaz, Prevalenceof metabolic syndrome in Saudi adult soldiers.Saudi medical journal, 2005. 26(9): p. 1360-1366.
[17]-Ali, N.S., A.K. Khuwaja, and K. Nanji, Retrospective analysis of metabolic syndrome: Prevalence and distribution in executive population in urban Pakistan.International journal of family medicine, 2012. 2012.
[18]-Nikbakht, H.-A., et al., Prevalence of metabolic syndrome and its components among a population-based study in south of ran, PERSIAN Kharameh cohort study.Clinical Epidemiology and Global Health, 2020. 8(3): p. 678-683.
[19]-Liang, X., et al., Prevalenceof Metabolic Syndrome in the United States National Health and Nutrition Examination Survey (NHANES) 2011-2018.medRxiv, 2021.
[20]-Ebrahimi, H., et al., Metabolic syndrome and its risk factorsamong middle aged population of Iran, a population based study.Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2016. 10(1): p. 19-22.
[21]-Hajian-Tilaki, K., et al., Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study.Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2014. 8(3): p. 170-176.
[22]-Mokhayeri, Y., et al., Metabolic syndrome prevalence in the Iranian adult’s general population and its trend: a systematic review and meta-analysis of observational studies.Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018. 12(3): p. 441-453.
[23]-Al-Rubeaan, K., Bawazeer, N., Al Farsi, Y., Youssef, A. M., Al-Yahya, A. A., AlQumaidi, H., ... & Al Rumaih, F. I. (2018). Prevalence of metabolic syndrome in Saudi Arabia-a cross sectional study.BMC endocrine disorders,18(1), 1-9.
[24]-Sarrafzadegan, N., et al., Metabolic syndrome in Iranianelderly.ARYA atherosclerosis, 2012. 7(4): p. 157.
[25]-Kuzuya, M., et al., Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort.Atherosclerosis, 2007. 191(2): p. 305-312.
[26]-Bruno, G., et al., Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.Diabetes care, 2004. 27(11): p. 2689-2694.
[27]-O'Neill, S. and L. O'Driscoll, Metabolic syndrome: a closer look at the growing epidemicand its associated pathologies.Obes Rev, 2015. 16(1): p. 1-12.
[28]-Welty, F.K., A. Alfaddagh, and T.K. Elajami,Targeting inflammation in metabolic syndrome.Translational research : the journal of laboratory and clinical medicine, 2016. 167(1): p. 257-280.
[29]-Prior, J.O., et al., Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.Circulation, 2005. 111(18): p. 2291-8.
[30]-Eckel, R.H., et al., The metabolic syndrome.The lancet, 2010. 375(9710 :)p. 181-183.
Authors
Copyright (c) 2022 Journal of Pure & Applied Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
In a brief statement, the rights relate to the publication and distribution of research published in the journal of the University of Sebha where authors who have published their articles in the journal of the university of Sebha should how they can use or distribute their articles. They reserve all their rights to the published works, such as (but not limited to) the following rights:
- Copyright and other property rights related to the article, such as patent rights.
- Research published in the journal of the University of Sebha and used in its future works, including lectures and books, the right to reproduce articles for their own purposes, and the right to self-archive their articles.
- The right to enter a separate article, or for a non-exclusive distribution of their article with an acknowledgment of its initial publication in the journal of Sebha University.
Privacy Statement The names and e-mail addresses entered on the Sabha University Journal site will be used for the aforementioned purposes only and for which they were used.